These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25745594)

  • 1. Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery.
    Thomas SN; Schudel A
    Curr Opin Chem Eng; 2015 Feb; 7():65-74. PubMed ID: 25745594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convective diffusion of nanoparticles from the epithelial barrier toward regional lymph nodes.
    Dukhin SS; Labib ME
    Adv Colloid Interface Sci; 2013 Nov; 199-200():23-43. PubMed ID: 23859221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Lymphatics for Nanoparticle Drug Delivery.
    McCright J; Naiknavare R; Yarmovsky J; Maisel K
    Front Pharmacol; 2022; 13():887402. PubMed ID: 35721179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic system of the pancreas.
    O'Morchoe CC
    Microsc Res Tech; 1997 Jun 1-15; 37(5-6):456-77. PubMed ID: 9220424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic targeting by albumin-hitchhiking: Applications and optimisation.
    Abdallah M; Müllertz OO; Styles IK; Mörsdorf A; Quinn JF; Whittaker MR; Trevaskis NL
    J Control Release; 2020 Nov; 327():117-128. PubMed ID: 32771478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design.
    Swartz MA; Hubbell JA; Reddy ST
    Semin Immunol; 2008 Apr; 20(2):147-56. PubMed ID: 18201895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional Lymphatic Delivery Systems Using Nanoparticles and Hydrogels for Anticancer Immunotherapy.
    Cho KJ; Cho YE; Kim J
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Material design for lymph node drug delivery.
    Schudel A; Francis DM; Thomas SN
    Nat Rev Mater; 2019 Jun; 4(6):415-428. PubMed ID: 32523780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming physiological barriers by nanoparticles for intravenous drug delivery to the lymph nodes.
    Trac N; Chung EJ
    Exp Biol Med (Maywood); 2021 Nov; 246(22):2358-2371. PubMed ID: 33957802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic vessels of the eye - old questions - new insights.
    Grüntzig J; Hollmann F
    Ann Anat; 2019 Jan; 221():1-16. PubMed ID: 30240907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin.
    Ryan GM; Kaminskas LM; Bulitta JB; McIntosh MP; Owen DJ; Porter CJH
    J Control Release; 2013 Nov; 172(1):128-136. PubMed ID: 23954628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic system: a prospective area for advanced targeting of particulate drug carriers.
    Singh I; Swami R; Khan W; Sistla R
    Expert Opin Drug Deliv; 2014 Feb; 11(2):211-29. PubMed ID: 24350774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination.
    McCright JC; Maisel K
    Tissue Barriers; 2020; 8(1):1695476. PubMed ID: 31775577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming negatively charged tissue barriers: Drug delivery using cationic peptides and proteins.
    Vedadghavami A; Zhang C; Bajpayee AG
    Nano Today; 2020 Oct; 34():. PubMed ID: 32802145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy.
    Thomas SN; Rohner NA; Edwards EE
    Annu Rev Biomed Eng; 2016 Jul; 18():207-33. PubMed ID: 26928210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indocyanine green nanoparticles undergo selective lymphatic uptake, distribution and retention and enable detailed mapping of lymph vessels, nodes and abnormalities.
    Kraft JC; Treuting PM; Ho RJY
    J Drug Target; 2018; 26(5-6):494-504. PubMed ID: 29388438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic transport and lymph node targeting of methotrexate-conjugated PEGylated dendrimers are enhanced by reducing the length of the drug linker or masking interactions with the injection site.
    Ryan GM; McLeod VM; Mehta D; Kelly BD; Stanislawski PC; Owen DJ; Kaminskas LM; Porter CJH
    Nanomedicine; 2017 Nov; 13(8):2485-2494. PubMed ID: 28821463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.
    Han S; Quach T; Hu L; Wahab A; Charman WN; Stella VJ; Trevaskis NL; Simpson JS; Porter CJ
    J Control Release; 2014 Mar; 177():1-10. PubMed ID: 24398334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial flow and its effects in soft tissues.
    Swartz MA; Fleury ME
    Annu Rev Biomed Eng; 2007; 9():229-56. PubMed ID: 17459001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic drainage of the peritoneal cavity in sheep.
    Abernethy NJ; Chin W; Hay JB; Rodela H; Oreopoulos D; Johnston MG
    Am J Physiol; 1991 Mar; 260(3 Pt 2):F353-8. PubMed ID: 2000952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.